Opinion/decision on a Paediatric investigation plan (PIP): Mektovi, binimetinib, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Oncology, PIP number: P/0349/2023

EMEA-001573-PIP03-23

Opinion/decision on a Paediatric investigation plan (PIP): Gazyvaro, Obinutuzumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0345/2023

Product-information requirements

Questions and answers on labelling requirements for centrally authorised metered dose inhalers containing fluorinated greenhouse gases

Minutes of the CVMP meeting 16-18 July 2024

Veterinary medicines European public assessment report (EPAR): Porcilis PCV M Hyo ID, Porcine circovirus and porcine enzootic pneumonia vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Cevac Salmune ETI K, Salmonella Enteritidis, Salmonella Typhimurium and Salmonella Infantis vaccine (inactivated) for chickens, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Cepeloron, spironolactone, Status: Authorised

Human medicines European public assessment report (EPAR): Comtess, entacapone, Date of authorisation: 16/09/1998, Revision: 29, Status: Authorised